A Pilot Study on the Collection of Adverse Event Data from the Patient Using an Electronic Platform in a Cancer Clinical Trial Unit
View abstract on PubMed
Summary
This summary is machine-generated.Patient-reported adverse event data in cancer trials show low agreement with clinician data but reduce staff workload. Electronic platforms improve data completeness and efficiency for adverse event collection.
Area Of Science
- Clinical Trials
- Patient Safety
- Data Management
Background
- Accurate adverse event (AE) data collection is vital for patient safety in cancer clinical trials.
- Traditional AE data collection workflows are evolving to incorporate patient-reported outcomes (PROs) for improved completeness.
- This study investigated the implementation of a patient-reported data workflow in a clinical trial setting.
Purpose Of The Study
- To evaluate the agreement between patient-reported and clinician-reported adverse event data.
- To assess the efficiency of using an electronic platform for AE data collection compared to traditional methods.
- To determine the impact of patient-reported data on data completeness in cancer clinical trials.
Main Methods
- A single-site study at a tertiary hospital in Australia.
- Participants used the 'My Health My Way' (MHMW) electronic platform to report symptoms weekly for 24 weeks.
- Comparison of AE data from MHMW with patient medical charts, assessing agreement (Kappa, Gwet's AC1) and time/missing data.
Main Results
- Low agreement observed between patient- and clinician-reported AEs (Kappa: -0.482, Gwet's AC1: -0.159).
- Only 30% of total AEs were reported by both sources.
- MHMW significantly reduced data compilation time (2.19 min vs. 5.73 min) and missing data points (1.4 vs. 7.8) compared to medical notes.
Conclusions
- Confirms low agreement between patient- and clinician-reported AE data.
- Electronic patient-reported platforms can significantly reduce research staff workload for AE data collection.
- Implementation of electronic platforms enhances efficiency and completeness of AE data in cancer trials.
Related Concept Videos
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Data collection gathers information needed to make accurate judgments about a patient's present condition. During a health history interview, subjective data is collected from the patient, their caregivers, or family members, and objective data is collected through observations and physical assessment. Patients are the primary source of subjective data. Thus information gathered from patients through interviews, observations, and physical examination is primary data. Secondary sources of...
The nursing history captures and records the patient's health status, so that a care plan evolves to meet the patient's individual needs. The nursing health history is a part of the initial assessment. A comprehensive history covers all health dimensions and plays a significant role in the assessment process. A comprehensive history includes the patient's biographical information, reasons for seeking health care, expectations, present and past health history, medications, and...

